ロード中...
The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad
Direct-to-consumer (DTC) genetic testing for disease susceptibility is largely dominated by 2 extremes—narrow tests that only screen for a few variants and broad tests that include dozens of genes. These tests may lack clinical utility for consumers wanting to understand their disease risks. In the...
保存先:
| 出版年: | JAMA |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8041057/ https://ncbi.nlm.nih.gov/pubmed/32074263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.22504 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|